Karel Raska JR MD - Modern Diagnostics

Karel Raska JR MD - Modern Diagnostics was paid $1.24M by Medicaid between Jan 2018 and Aug 2022, across 74 billing codes. Its largest line is 88305, Level IV - Surgical pathology, gross and microscopic examination — 39% of everything it billed.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	30,572	$322K
2019	31,483	$319K
2020	19,182	$191K
2021	26,806	$280K
2022	5,808	$125K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
88305	Level IV - Surgical pathology, gross and microscopic examination	39%	8,400	7,528	$478K
88307		12%	3,152	3,130	$153K
88341		5.9%	2,367	2,195	$73K
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	5.4%	1,758	1,638	$67K
80048	Basic metabolic panel (calcium, ionized)	4.7%	7,778	2,996	$58K
80053	Comprehensive metabolic panel	4.2%	7,836	4,776	$52K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	3.0%	11,758	6,656	$37K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	3.0%	998	834	$37K
88342		2.0%	2,451	2,270	$24K
82803		1.6%	1,669	1,433	$20K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	1.4%	615	560	$18K
83735		1.4%	6,169	2,527	$17K

62 more codes

86885		1.2%	3,285	$15K
87040		1.2%	2,512	$15K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	1.2%	370	$15K
85027		1.1%	4,634	$14K
84484		<1%	1,307	$10K
84030		<1%	2,333	$10K
83880		<1%	287	$9K
83605		<1%	874	$8K
86901		<1%	5,339	$7K
86900		<1%	5,333	$7K
84100		<1%	4,082	$7K
82248		<1%	2,461	$7K
84443	Thyroid stimulating hormone (TSH)	<1%	449	$7K
86140		<1%	3,587	$6K
83020		<1%	932	$5K
87086	Culture, bacterial; quantitative colony count, urine	<1%	1,238	$5K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	<1%	163	$5K
85610		<1%	2,471	$5K
86880		<1%	1,311	$5K
87186		<1%	581	$4K
85730		<1%	2,003	$4K
87070		<1%	672	$3K
83690		<1%	864	$3K
81003		<1%	3,006	$2K
87205		<1%	834	$2K
87077		<1%	415	$2K
87400		<1%	400	$2K
82550		<1%	390	$1K
87420		<1%	179	$1K
84145		<1%	233	$1K
83036	Hemoglobin; glycosylated (A1C)	<1%	291	$1K
82728		<1%	142	$980.03
82570		<1%	524	$940.65
88104		<1%	84	$910.40
88173		<1%	24	$711.27
80061	Lipid panel	<1%	86	$648.79
88304		<1%	41	$599.72
85060		<1%	107	$593.53
87641		<1%	81	$566.64
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	13	$494.00
88142		<1%	27	$486.00
85379		<1%	292	$468.54
85044		<1%	201	$444.00
88172		<1%	12	$440.25
85652		<1%	506	$399.28
86592		<1%	612	$399.01
84439		<1%	39	$380.00
85014		<1%	397	$372.00
86703		<1%	33	$342.00
85018		<1%	408	$315.60
81015		<1%	1,766	$301.00
83615		<1%	228	$273.20
88363		<1%	28	$271.93
88177		<1%	12	$269.94
84156		<1%	189	$261.53
83550		<1%	39	$199.44
83540		<1%	53	$196.66
87081		<1%	25	$162.00
82150		<1%	30	$130.50
87075		<1%	25	$126.00
88311		<1%	14	$60.00
82397		<1%	26	$19.50

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialRASKA, KAREL (OWNER)